Rocket Lab (NASDAQ:RKLB - Get Free Report) was upgraded by stock analysts at Berenberg Bank to a "strong-buy" rating in a note issued to investors on Wednesday, Zacks reports.
RKLB has been the subject of several other reports. Needham & Company LLC restated a "buy" rating on shares of Rocket Lab in a research report on Tuesday, August 11th. Bank of America reduced their price objective on Rocket Lab from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday. New Street Research assumed coverage on Rocket Lab in a report on Wednesday, May 13th. They issued a "buy" rating and a $150.00 price objective on the stock. Morgan Stanley reissued an "overweight" rating on shares of Rocket Lab in a research note on Wednesday, July 8th. Finally, KeyCorp restated an "overweight" rating on shares of Rocket Lab in a report on Tuesday, August 11th. Four investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Rocket Lab currently has an average rating of "Moderate Buy" and a consensus price target of $108.83.
Read Our Latest Analysis on RKLB
Rocket Lab Trading Up 1.1%
RKLB stock opened at $63.81 on Wednesday. The company has a market capitalization of $38.18 billion, a PE ratio of -236.32 and a beta of 2.60. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. Rocket Lab has a one year low of $37.57 and a one year high of $151.00. The company's 50 day moving average price is $75.64 and its two-hundred day moving average price is $84.89.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million during the quarter, compared to analysts' expectations of $231.62 million. As a group, analysts predict that Rocket Lab will post -0.2 earnings per share for the current fiscal year.
Insider Activity at Rocket Lab
In other Rocket Lab news, CEO Peter Beck sold 1,298,622 shares of the company's stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $84.92, for a total transaction of $110,278,980.24. Following the completion of the transaction, the chief executive officer owned 2,715,181 shares of the company's stock, valued at $230,573,170.52. This represents a 32.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 88,000 shares of the stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $107.98, for a total value of $9,502,240.00. Following the completion of the sale, the senior vice president owned 264,705 shares of the company's stock, valued at approximately $28,582,845.90. This trade represents a 24.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 3,484,214 shares of company stock worth $304,166,848 over the last 90 days. 8.40% of the stock is owned by insiders.
Institutional Trading of Rocket Lab
Several large investors have recently added to or reduced their stakes in RKLB. Mcguire Capital Advisors Inc. bought a new position in Rocket Lab in the 4th quarter worth $27,000. Zions Bancorporation National Association UT purchased a new stake in shares of Rocket Lab in the 4th quarter worth about $28,000. EverSource Wealth Advisors LLC boosted its stake in shares of Rocket Lab by 109.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer's stock valued at $28,000 after purchasing an additional 416 shares in the last quarter. Gordian Capital Singapore Pte Ltd bought a new stake in shares of Rocket Lab during the 4th quarter valued at about $29,000. Finally, Reflection Asset Management purchased a new position in shares of Rocket Lab during the fourth quarter valued at about $30,000. Institutional investors own 71.78% of the company's stock.
Key Stories Impacting Rocket Lab
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Rocket Lab completed its 94th Electron mission, successfully deploying Synspective’s StriX Earth-imaging satellite. The launch preserved Rocket Lab’s perfect record for Synspective, which has 16 additional Electron missions booked through 2030, supporting visibility for the company’s launch-services revenue. Rocket Lab launches 94th Electron mission
- Positive Sentiment: Berenberg initiated coverage with a Buy rating, arguing that the space industry could approach $1 trillion and that Rocket Lab is positioned to benefit from launch, satellite and national-security demand. Other bullish commentary points to the company’s record backlog, expanding end-to-end platform and Neutron opportunity. Berenberg initiates coverage
- Positive Sentiment: ARK Invest reportedly purchased roughly $32 million of RKLB shares during the selloff, signaling continued conviction from Cathie Wood. The purchase helped offset investor concern over the stock’s recent decline. Cathie Wood buys Rocket Lab shares
- Neutral Sentiment: Rocket Lab continues to attract attention as a major space stock benefiting from SpaceX-related sector enthusiasm, but upcoming earnings will be important for investors assessing revenue growth, losses and progress toward Neutron.
- Negative Sentiment: Blue Origin won NASA’s approximately $700 million Mars communications contract, beating Rocket Lab. The loss highlights intense competition for high-value government work and removes a potentially significant future program. Blue Origin wins NASA Mars contract
- Negative Sentiment: Analysts and commentators remain concerned that Rocket Lab is spending ahead of Neutron, its larger rocket intended to improve long-term economics, while the inaugural launch has not yet occurred. Technical indicators have also flashed bearish signals, and Bank of America lowered its price target to $110.
- Negative Sentiment: Insider filings show extensive selling and no reported insider purchases over the past six months, including substantial sales by executives. Combined with the stock’s still-elevated valuation and recent losses, the activity may reinforce caution despite strong revenue and backlog growth.
About Rocket Lab
(
Get Free Report)
Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.